Weekly topotecan plus paclitaxel induces promising response rates with very low toxicity in advanced non-small-cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel for non-small cell lung cancer

By Ramalingam Sakkaraiappan   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1771-1780

Informa Healthcare

Access to resources Recommend Favorite

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

By Goto Yasushi  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1548-1556

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Phase 2 Study of Radiotherapy Alone Versus Radiotherapy with Paclitaxel in Non-small Cell Lung Cancer

By Sarihan S   Kayisogullari U   Ercan I   Engin K  

The Journal of International Medical Research, Vol. 32, Iss. 4, 2004-07 ,pp. : 375-383

Field House Publishing

Access to resources Recommend Favorite